ANPEP and non-small cell lung carcinoma: On the other hand, both for stage III NSCLC patients and for NSCLC patients with pN2 lymph node status, CD13 expression in endothelial cells and vessel-associated stroma cells was identified to be associated with reduced overall survival (p < 0.05 both analyses, log rank test).